|
RSBN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.93579638166852E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05250030912885E-10 |
| Normal-vs-Stage2 |
3.630400E-04 |
| Normal-vs-Stage3 |
1.26660000043799E-07 |
| Normal-vs-Stage4 |
2.21049999999945E-05 |
| Stage1-vs-Stage2 |
6.500600E-01 |
| Stage1-vs-Stage3 |
7.789600E-01 |
| Stage1-vs-Stage4 |
7.376600E-01 |
| Stage2-vs-Stage3 |
4.842200E-01 |
| Stage2-vs-Stage4 |
5.033600E-01 |
| Stage3-vs-Stage4 |
8.596200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99900096475858E-11 |
| Normal-vs-AfricanAmerican |
3.12249999967484E-07 |
| Normal-vs-Asian |
2.47150000000085E-05 |
| Caucasian-vs-AfricanAmerican |
4.534800E-01 |
| Caucasian-vs-Asian |
3.062400E-01 |
| AfricanAmerican-vs-Asian |
1.582420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.40933964288115E-12 |
| Normal-vs-Female |
1.989400E-04 |
| Male-vs-Female |
1.994410E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.24169999948798E-07 |
| Normal-vs-Extreme_Weight |
1.64619984310832E-10 |
| Normal-vs-Obese |
2.30719999994022E-07 |
| Normal-vs-Extreme_Obese |
1.58191999999335E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.883800E-01 |
| Normal_Weight-vs-Obese |
3.058200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.388000E-01 |
| Extreme_Weight-vs-Obese |
1.833960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.008000E-01 |
| Obese-vs-Extreme_Obese |
3.880400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.75959999999731E-05 |
| Normal-vs-Age(41-60Yrs) |
1.87539999974007E-07 |
| Normal-vs-Age(61-80Yrs) |
9.55791001899797E-13 |
| Normal-vs-Age(81-100Yrs) |
6.60490000470304E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.153400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.590000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.332830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.038110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.234500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.79339987305127E-10 |
| Normal-VS-Type2 PRCC |
2.61646260213411E-12 |
| Normal-VS-KIRP CIMP |
3.58049999999999E-05 |
| Normal-VS-Unclassified PRCC |
2.857200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.407800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.515600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.697210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.504800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.267580E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.509000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.72955008490317E-14 |
| Normal-vs-N1 |
1.0628000000068E-06 |
| Normal-vs-N2 |
6.210800E-04 |
| N0-vs-N1 |
2.371200E-01 |
| N0-vs-N2 |
8.405400E-01 |
| N1-vs-N2 |
7.480800E-01 |
|
|
